1Yilmaz A, Emam D, Unsal E, et al. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer [J]. Arch Med Res, 2007,38 (7) : 764 --768.
2Yoo J, Jung JH, Lee MA, et al. Immunohistoehemieal analysis of non-small cell lung cancer :correlation with clinical parameters and prognosis [J]. J Korean Med Sci, 2007,22 (2) : 318-- 325.
7Seto T, Higashiyama M, Funai H, et al. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage Ⅰ non- smaLl-cell lung cancer [J]. Lung Cancer, 2006,53 (1) : 91--96.
8Laack E, Scheffler A, Burkholder I,et al. Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) [J]. Lung Cancer, 2005,50(1) : 51-- 58.
9Iwasaki A, Kuwahara M, Yoshinaga Y, et al. Basic fibroblast growth factor ( bFGF ) and vascular endothelial growth factor(VEGF) levels ,as prognostic indicators in NSCLC [J]. Eur J Cardiothorac Surg, 2004,25(3) :443--448.
10Kaya A,Ciledag A,Gulbay BE,et al. The prognostics significance of vascular endothelial growth factor levels in sera of non-small-cell lung cancer patients[J]. Respir Med, 2004,98 (7) : 632-- 636.
8[1]Gunningham SP,Currie MJ,Han C,et al.Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas:regulation by the von Hippel-Lindau gene and hypoxia.Cancer Res,2001,61(7):3206-3211.
9[2]Lang S,Hartner A,Sterzel RB,et al.Requirement of cyclin D1 in mesangial cell mitogenesis.J Am Soc Nephrol,2000,11 (8):1398-1408.
10[3]Maeda K,Chung YS,Ogawa Y,et al.Prognostic value of vascular endothelial growth factor expression in gastric carcinoma.Cancer,1996,77(5):858-863.
7Tang R, Faussat AM, Majdak P, et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1 [ J ]. Leukemia, 2004,18 (7) : 1246 - 1251.
8Glozak MA, Sengupta N, Zhang X, et al. Acetylation and deacetylation of non - histone proteins [ J ]. Gene, 2005,363 : 15 - 23.
9Blaheta RA, Michaelis M, Driever PH, et al. Evolving anticancer drug valproic acid:insights into the mechanism and clinical studies [ J ]. Med Res Rev, 2005,25 (4) : 383 - 397.
10Carmeliet P. VEGF as a key mediator of angiogenesis in cancer [ J]. Oncology,2005,69 (supple3) :4 - 10.
